Professional Documents
Culture Documents
net/publication/277599462
CITATIONS READS
7 1,977
4 authors, including:
Some of the authors of this publication are also working on these related projects:
Low-level laser therapy increases interleukin-1β in gingival crevicular fluid and enhances the rate of orthodontic tooth movement View project
All content following this page was uploaded by Ameet Revankar on 08 June 2015.
ABSTRACT
Objective: To determine the effect of Vitamin D3 on the rate and amount of orthodontic tooth
movement in humans when injected locally at the site.
Materials and Methods: A prospective, split-mouth clinical trial was carried out on 15 subjects
who were referred for bilateral therapeutic extraction of the first premolars followed by canine
retraction in the maxillary arch. Vitamin D3 in a vehicle of local anesthetic solution was injected into
the buccal vestibule immediately distal to the canine to be retracted on the experimental side; on
the contralateral side, only local anesthetic solution as control was injected into the correspnding
site on the 7th, 21st, and 47th days of canine retraction. The amount of canine retraction was
assessed using the palatal rugae as stable landmarks, and the values obtained were compared
using pre- and postcanine retraction occlusograms.
Results: The experimental teeth whose gingivae had received injections containing Vitamin D3
had moved considerably less than had the matched control teeth (P , .001).
Conclusions: Localized injection of vitamin D3 produces a significantly decreased rate and
amount of tooth movement in humans. (Angle Orthod. 0000;00:000–000.)
KEY WORDS: Vitamin D3; Canine retraction; Orthodontic tooth movement; Occlusograms; Palatal
rugae
Figure 1. Showing (a) calibration of force using Dontrix gauge, (b) placement of NiTi closed coil spring, and (c) local injection of Vitamin D3 in the
labial vestibule distal to the canine.
Board approval was obtained from the SDM College of (10 mg)/day.18 Vitamin D3 is a safe drug for human
Dental Sciences & Hospital, Dharwad, Karnataka, beings,20,21,22 and it can be either injected intramuscu-
India. Healthy subjects with no radiographic evidence larly20,21 or administered by local infiltration into the oral
of periodontal disease (probing depth values less than cavity.22 One mL of commercially available Vitamin D3
3 mm for the entire dentition) and referred for (Arachitol-6l, Solvay Pharma India Pvt Ltd, Mumbai,
therapeutic extraction of bilateral maxillary first pre- India) containing 15 mg of Vitamin D3 per mL of
molars (Angle Class II division 1 cases, with crowding solution was dissolved in 999 mL of 2% Xylocaine
and bimaxillary protrusion) and who had not used anti- containing adrenaline 1:200,000 (AstraZeneca
inflammatory drugs, steroids, or antibiotics over the Pharma Ltd, New Delhi, India) to prepare a stock
prior 3 months were selected for the study. The solution having 15 mg (600 IU) of Vitamin D3 per mL of
exclusion criteria were subjects with systemic/bone/ solution for local injection.
metabolic/hormonal disease, hypersensitivity to vita-
min D or its analogues/derivatives, or subjects who Administration of the Solution (Figure 1C)
had undergone a major surgical procedure or who had
Experimental side. One milliliter of the prepared
artificial valves or joints.
stock solution was injected into the buccal vestibule at
the level of the distal margin of the root of the canine
Procedure
using a commercially available 2-mL syringe with a 1
Each subject’s maxillary arch was divided into right- 1/2-inch, 26-gauge needle (Unolok Luer lock syringe,
left and randomly allocated as experimental and Hindustan Syringes & Medical Devices Ltd, New Delhi,
control sides. The subjects were orthodontically India).
treated using a preadjusted edgewise appliance Control side. One milliliter of the control solution of
(0.022 3 0.028-inch slot, MBT prescription, 3M Unitek, the local anesthetic was administered at a similar site
Monrovia, Calif). Initial leveling and aligning were on the distal portion of the contralateral canine. One
carried out using 0.016-inch nickel titanium (Optima, milliliter of the stock solution was injected three times
Orthodontic Supplies Ltd, Leicestershire, UK) and during treatment (on the 7th, 21st, and 47th days of
0.018-inch round stainless steel wires (AJ Wilcock, canine retraction) on both sides.
Whittlesea, Victoria, Australia). After complete healing
of the alveolar sockets, individual canine retraction Data Collection
was carried out on 0.019 3 0.025-inch stainless steel
The exact amount of canine retraction was assessed
wire (Optima), using NiTi closed coil springs (Ortho-
with occlusograms using the palatal rugae as stable
force, G&H Wire Co, Franklin, Ind) placed between the
landmarks for taking readings of tooth movements
maxillary first molars and canines, delivering 150 g of
before and after 60 days of canine retraction.
force. The force was calibrated using a Dontrix gauge
(Libral Traders Pvt Ltd, New Delhi, India) (Figure 1a,b).
Fabrication of Occlusograms (Figure 2A)
After the alignment stage, anchorage was reinforced
using transpalatal arches on the maxillary first molars in The pre- and postretraction casts were scanned
all cases. using a flatbed scanning machine (Scanjet G3010,
Hewlett-Packard, Palo Alto, Calif) along with two
15-cm metal rulers placed on the x- and y-axes to
Preparation of the Solution
help ascertain the magnification error. The scanned
The normal circulating level of vitamin D3 in humans images were then printed. The printouts were traced
is 15 pg/mL (1 pg 5 1025 g). The recommended dietary on cellulose acetate paper using a 0.3-mm black lead
allowance of vitamin D in human adults is 400 IU pencil (micro pencil; Staedtler Mars GmbH & Co,
Figure 2. Showing (a) fabrication of occlusograms and (b) points marked on the traced images. (a–b) midpalatal suture, (c) medial end of right
third palatal ruga, (d) medial end of left third palatal ruga, (e) central fossa of maxillary right first permanent molar, (f) central fossa of maxillary left
first permanent molar, (g) cusp tip of right maxillary canine, and (h) cusp tip of left maxillary canine.
18. Collins MK, Sinclair PM. The local use of vitamin D to tooth movement. Int J Pharm Pharm Sci. 2011;3:
increase the rate of orthodontic tooth movement. 139–143.
Am J Orthod Dentofacial Orthop. 1988;94:278–284. 23. Reynolds JJ, Hollick MF, DeLuca HF. The role of vitamin D
19. Kale S, Kocadereli I, Atila P, Asan E. Comparison of the metabolites in bone resorption. Calcif Tissue Res. 1973;12:
effects of 1,25-dehydroxycholecalciferol and prostaglandin 295–301.
E2 on orthodontic tooth movement. Am J Orthod Dentofacial 24. Jones G, Hogan DB, Yendt E, Hanley DA. Prevention and
Orthop. 2004;125:607–614. management of osteoporosis: consensus statements from
20. Diamond TH, Ho KW, Rohl PG, Meerkin M. Annual the Scientific Advisory Board of the Osteoporosis Society of
intramuscular injection of a megadose of cholecalciferol for Canada: Vitamin D metabolites and analogs in the treatment
treatment of vitamin D deficiency: efficacy and safety data. of osteoporosis. Can Med Assoc J. 1996:155: 955–961.
Med J Aust. 2005;183:10–12. 25. Dechant KL, Goa KL. Calcitriol: a review of its use in the
21. Einarsdottir K, Preen DB, Clay TD, Kiely L, Holman CDJ, treatment of postmenopausal osteoporosis and its potential
Cohen LD. Effect of a single ‘‘megadose’’ intramuscular in corticosteroid-induced osteoporosis. Drugs Aging. 1994;
vitamin D (600,000 IU) injection on vitamin D concentrations 5:300–317.
and bone mineral density following biliopancreatic diversion 26. Kawakami M, Takamo-Yamamoto T. Local injection of 1,25-
surgery. Obes Surg. 2010;20:732–737. dihydroxyvitamin D3 enhanced bone formation for tooth
22. Al-Hasani NR, Al-Bustani AI, Ghareeb MM, Hussain SA. stabilization after experimental tooth movements in rats.
Clinical efficacy of locally injected calcitriol in orthodontic J Bone Miner Metab. 2004;22:541–546.